Oak Thistle LLC Purchases 3,440 Shares of Amedisys, Inc. (NASDAQ:AMED)

Oak Thistle LLC boosted its stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 97.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,964 shares of the health services provider's stock after purchasing an additional 3,440 shares during the period. Oak Thistle LLC's holdings in Amedisys were worth $632,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. HBW Advisory Services LLC bought a new stake in shares of Amedisys in the 4th quarter worth approximately $38,000. Versant Capital Management Inc grew its position in shares of Amedisys by 68.5% in the 4th quarter. Versant Capital Management Inc now owns 450 shares of the health services provider's stock worth $41,000 after buying an additional 183 shares during the last quarter. KBC Group NV bought a new stake in shares of Amedisys in the 3rd quarter worth approximately $63,000. Signaturefd LLC grew its position in shares of Amedisys by 20.9% in the 3rd quarter. Signaturefd LLC now owns 1,367 shares of the health services provider's stock worth $132,000 after buying an additional 236 shares during the last quarter. Finally, CWM LLC grew its position in shares of Amedisys by 14.5% in the 3rd quarter. CWM LLC now owns 2,190 shares of the health services provider's stock worth $211,000 after buying an additional 277 shares during the last quarter. 94.36% of the stock is owned by hedge funds and other institutional investors.

Amedisys Trading Up 0.1 %

Shares of AMED stock traded up $0.12 during trading hours on Thursday, reaching $91.98. The company's stock had a trading volume of 327,978 shares, compared to its average volume of 387,888. The stock has a market capitalization of $3.01 billion, a P/E ratio of 36.50, a P/E/G ratio of 1.83 and a beta of 0.72. Amedisys, Inc. has a one year low of $82.15 and a one year high of $98.95. The firm's fifty day simple moving average is $89.22 and its 200 day simple moving average is $94.42. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05.

Amedisys (NASDAQ:AMED - Get Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The health services provider reported $1.00 earnings per share for the quarter, missing analysts' consensus estimates of $1.19 by ($0.19). Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The business had revenue of $587.67 million during the quarter, compared to the consensus estimate of $586.75 million. During the same quarter in the prior year, the business posted $0.98 earnings per share. Amedisys's quarterly revenue was up 5.7% compared to the same quarter last year. Equities research analysts expect that Amedisys, Inc. will post 4.43 EPS for the current year.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.